{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/433578764"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Preliminary results from the PROPHYSES trial show that CHC patients age 65 and older have lower rates of virologic response even after correcting for factors such as co-morbidities and medication adherence.In this same vein, patients with co-morbid conditions ??? such as chronic cardiopulmonary disorders ??? are another population where treatment now may be beneficial." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "hepatitiscnewdrugresearch.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/134328572"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/433578764" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/81301640"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/433578764"] } } }
